Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL17820158

Cc1ccc(C2CC2)nc1.N

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.50
CCR5 P51681 1/20 0.50
CCR8 P51685 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
OPRM1 P35372 1/20 0.44
OPRL1 P41146 1/20 0.44
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
NOTUM Q6P988 2/20 0.42
NOS3 P29474 1/20 0.41
NOS2 P35228 1/20 0.41
PDE10A Q9Y233 4/20 0.41
KDM5A P29375 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAP4K4 O95819 1/20 0.39
DGAT1 O75907 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL827646 0.98 CCR1 (0.52) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL15448338 0.90 CCR1 (0.45) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL20624050 0.90 CCR1 (0.45) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL23331881 0.89 CCR1 (0.48) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL12093753 0.89 CCR1 (0.48) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL18971112 0.88 CCR1 (0.43) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL15122188 0.88 PDE10A (0.48) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL6919321 0.84 MAPK1 (0.46) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL14186232 0.84 DRD4 (0.46) CCR1CCR5CCR8HDAC6OPRM1
SCHEMBL103848 0.84 CCR1 (0.43) CCR1CCR5CCR8HDAC6OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3042900-B1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2020-09-23 EP disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
EP-3042900-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF Fujifilm Corporation (JP) 2016-07-13 EP disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF PRMT7, RBBP7, RER1 CCR1 666/4885CCR5 1465/4885CCR8 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.